Τετάρτη 23 Μαΐου 2018

Impact of race on dose selection of molecular-targeted agents in early-phase oncology trials

Impact of race on dose selection of molecular-targeted agents in early-phase oncology trials

Impact of race on dose selection of molecular-targeted agents in early-phase oncology trials, Published online: 24 May 2018; doi:10.1038/s41416-018-0102-1

Impact of race on dose selection of molecular-targeted agents in early-phase oncology trials

https://ift.tt/2J5lcDl

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου